Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 214 results found since Jan 2013.

Influenza vaccine and subsequent development of zoster
CONCLUSIONS: There was a slight increase in risk of HZ in people receiving influenza vaccine in the first 1-15 days after vaccination.PMID:36114790 | DOI:10.1111/irv.13055
Source: Herpes - September 17, 2022 Category: Infectious Diseases Authors: Kai-Che Wei Yu-Chia Chang Yu-Tung Huang Source Type: research

Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19
CONCLUSION: In summary, it seems that Sinopharm COVID-19 vaccine adverse effects were not serious among stem cell transplant recipients. However, it may lead to some severe complications in the population. Vaccine failure against the Delta and Omicron variants of COVID-19 has been reported among more than one-third of BMT patients; however, no mortality was observed among BMT patients infected with the new variants of COVID-19.PMID:35927906 | DOI:10.2174/1574886317666220801122822
Source: Current Drug Safety - August 5, 2022 Category: Drugs & Pharmacology Authors: Ali Ghasemi Rozita Khodashahi Mohsen Aliakbarian Ebrahim Khaleghi Baran Razmkhah Mehrsa Vahdatinia Mahdi Salimi Far Omolbanin Bakhti Source Type: research

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2  vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | PMC:PMC9340059 | DOI:10.1016/j.ejim.2022.07.022
Source: European Journal of Internal Medicine - August 5, 2022 Category: Internal Medicine Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research

Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19
CONCLUSION: In summary, it seems that Sinopharm COVID-19 vaccine adverse effects were not serious among stem cell transplant recipients. However, it may lead to some severe complications in the population. Vaccine failure against the Delta and Omicron variants of COVID-19 has been reported among more than one-third of BMT patients; however, no mortality was observed among BMT patients infected with the new variants of COVID-19.PMID:35927906 | DOI:10.2174/1574886317666220801122822
Source: Current Drug Safety - August 5, 2022 Category: Drugs & Pharmacology Authors: Ali Ghasemi Rozita Khodashahi Mohsen Aliakbarian Ebrahim Khaleghi Baran Razmkhah Mehrsa Vahdatinia Mahdi Salimi Far Omolbanin Bakhti Source Type: research

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2  vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | DOI:10.1016/j.ejim.2022.07.022
Source: Herpes - August 5, 2022 Category: Infectious Diseases Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research

Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19
CONCLUSION: In summary, it seems that Sinopharm COVID-19 vaccine adverse effects were not serious among stem cell transplant recipients. However, it may lead to some severe complications in the population. Vaccine failure against the Delta and Omicron variants of COVID-19 has been reported among more than one-third of BMT patients; however, no mortality was observed among BMT patients infected with the new variants of COVID-19.PMID:35927906 | DOI:10.2174/1574886317666220801122822
Source: Current Drug Safety - August 5, 2022 Category: Drugs & Pharmacology Authors: Ali Ghasemi Rozita Khodashahi Mohsen Aliakbarian Ebrahim Khaleghi Baran Razmkhah Mehrsa Vahdatinia Mahdi Salimi Far Omolbanin Bakhti Source Type: research

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2  vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | PMC:PMC9340059 | DOI:10.1016/j.ejim.2022.07.022
Source: European Journal of Internal Medicine - August 5, 2022 Category: Internal Medicine Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research

Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19
CONCLUSION: In summary, it seems that Sinopharm COVID-19 vaccine adverse effects were not serious among stem cell transplant recipients. However, it may lead to some severe complications in the population. Vaccine failure against the Delta and Omicron variants of COVID-19 has been reported among more than one-third of BMT patients; however, no mortality was observed among BMT patients infected with the new variants of COVID-19.PMID:35927906 | DOI:10.2174/1574886317666220801122822
Source: Current Drug Safety - August 5, 2022 Category: Drugs & Pharmacology Authors: Ali Ghasemi Rozita Khodashahi Mohsen Aliakbarian Ebrahim Khaleghi Baran Razmkhah Mehrsa Vahdatinia Mahdi Salimi Far Omolbanin Bakhti Source Type: research

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2  vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | PMC:PMC9340059 | DOI:10.1016/j.ejim.2022.07.022
Source: European Journal of Internal Medicine - August 5, 2022 Category: Internal Medicine Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research